AbbVie named its chief executive, Robert Michael, to succeed Richard Gonzalez as chairman of the biopharmaceutical company, effective July 1. AbbVie on Friday said Gonzalez, who has been chairman ...

AbbVie’s former CEO Richard Gonzalez—who collected a $25.7 million payout for his final full year on the job in 2023—often ranked among the industry’s highest-paid CEOs during his tenure ...

AbbVie’s CEO Richard Gonzalez took a huge bet that Rova-T would be the next big thing in oncology. Rova-T had a convincing-looking mechanism of action, consisting of an antibody that locks onto ...

He’ll replace longtime chief executive officer and avid dealmaker Richard Gonzalez in July. Read More: ‘Ozempic Face’ Seen Driving Botox Sales, AbbVie Says Still, AbbVie’s aesthetics ...

He will succeed Richard A. Gonzalez, who formerly served as AbbVie's CEO and has been chairman since the Company's formation in 2013. "I want to extend my heartfelt gratitude to Rick for his ...

AbbVie has moved to shore up its pipeline following ... across solid tumours and haematologic malignancies,” remarked Richard Gonzalez, AbbVie’s chairman and chief executive.